BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33268608)

  • 21. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
    Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
    Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Park SH; Cheon H; Chong GO; Jeong SY; Lee JE; Kang MK; Kim MY; Lee JW; Park J; Kim JC
    Gynecol Oncol; 2018 Mar; 148(3):449-455. PubMed ID: 29329882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
    Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
    Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
    Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for pelvic lymph node debulking in advanced cervical cancer?
    Kupets R; Thomas GM; Covens A
    Gynecol Oncol; 2002 Nov; 87(2):163-70. PubMed ID: 12477446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
    Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
    Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps for Gynecological Malignancies: Results from a Large, Multicenter, Retrospective Analysis.
    Di Donna MC; Sozzi G; Cucinella G; Giallombardo V; Gallotta V; Uccella S; Garzon S; Scambia G; Laganà AS; Chiantera V
    J Minim Invasive Gynecol; 2022 Sep; 29(9):1083-1091. PubMed ID: 35649479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
    Olthof EP; Wenzel H; van der Velden J; Spijkerboer AM; Bekkers R; Beltman JJ; Nijman HW; Slangen B; Smolders R; van Trommel N; Zusterzeel PLM; Zweemer R; Stalpers LJA; van der Aa M; Mom C
    Int J Gynecol Cancer; 2022 Jul; 32(7):861-868. PubMed ID: 35483738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic debulking of bulky lymph nodes in women with cervical cancer: indication and surgical outcomes.
    Tozzi R; Lavra F; Cassese T; Campanile RG; Pedicini V; Bignardi M; Scorsetti M; Bertuzzi A
    BJOG; 2009 Apr; 116(5):688-92. PubMed ID: 19220242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coincidental detection of T-cell rich B cell lymphoma in the para-aortic lymph nodes of a woman undergoing lymph node dissection for cervical cancer: a case report.
    Abali H; Eren OO; Erman M; Uner AH; Kose F; Guler N
    Int J Gynecol Cancer; 2003; 13(5):687-9. PubMed ID: 14675356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
    Wang W; Liu X; Meng Q; Zhang F; Hu K
    PLoS One; 2019; 14(4):e0214498. PubMed ID: 30986236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.